Post-warranty Preventive Maintenance and Repair Services on a liquid chromatography mass spectrometry (LC/MS) system

The Food and Drug Administration Office of Acquisition and Grant Services seeks post-warranty preventive maintenance and repair services on a Dionex Ultimate 3000 NCS-3500RS NANO UHPLC system interfaced to an ECLIPSE ORBITRAP ETD Mass Spectrometer, with quotes due June 15, 2026 by 1:00 P.M. Central Time. This is a small business set-aside under NAICS 811210, Electronic and Precision Equipment Repair and Maintenance, with a $34 million small business size standard.

Place of performance is the FDA/CBER White Oak Campus in Silver Spring, Maryland. The contract consists of one base year (July 1, 2026 through June 30, 2027) plus two optional one-year periods, firm fixed pricing required for all line items. Services include one scheduled on-site preventive maintenance visit annually with parts, unlimited on-site corrective maintenance within three business days of call (after two business days of attempted remote resolution), unlimited technical support Monday through Friday 8:00 A.M. to 5:00 P.M. Eastern Time, access to OEM technical developments and updates, and OEM-certified replacement parts and labor. Shipping and handling must be included in pricing.

Evaluation criteria are technical capability, past performance within the last three years for the same or substantially similar services, and price, with technical capability and past performance collectively more important than price. Contractors must certify FAR 52.222-48 Service Contract Act compliance, submit Section 508 accessibility conformance reports for invoices and service records, provide detailed technical information demonstrating capability to meet all requirements, and include their Unique Entity ID with the quote. Payment terms are Net 30 days after government acceptance of invoices submitted electronically through the Department of Treasury Invoice Processing Platform. The Contracting Officer is Warren Dutter (301-796-2486, warren.dutter@fda.hhs.gov).